mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.005 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |